Brion W. Murray - Concepedia

Author

Brion W. Murray

Also Known As

B MURRAY, B W Murray, B. Murray, B.W. Murray, Brion Murray, Brion W Murray, Brion W. Murray, Brion William Murray, Murray, Brion W., Nichol Miller

176

Publications

13.3K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Scripps Research Institute SignalRx Pharmaceuticals (United States)

About

Brion W. Murray is an author at Pfizer (United States) specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	24	3.8K
2	Natural Sciences	14	14	2.9K
3	Health Sciences	2	2	81
4	Engineering	1	1	105
5	Allergy	1	1	25

Brion W. Murray

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Brydon L. Bennett, Dennis T. Sasaki, Brion W. Murray, Proceedings of the National Academy of Sciences	2001	2.5K
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation Frank Mercurio, Hengyi Zhu, Brion W. Murray, Science ImmunologyMolecular BiologyInflammationSignaling PathwayCell Regulation	1997	2K
PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse Peter Hornbeck, Jon M. Kornhauser, Bin Zhang, Nucleic Acids Research	2011	1.7K
Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3 Dana D. Hu‐Lowe, Helen Y. Zou, Maren L. Grazzini, Clinical Cancer Research	2008	620
Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors Michele McTigue, Brion W. Murray, Jeffrey H. Chen, Proceedings of the National Academy of Sciences	2012	538
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19 Robert L. Hoffman, Robert S. Kania, Mary A. Brothers, Journal of Medicinal Chemistry	2020	518
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance Ping Chen, Nathan V. Lee, Wenyue Hu, Molecular Cancer Therapeutics	2016	414
IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex Frank Mercurio, Brion W. Murray, Andrej Shevchenko, Molecular and Cellular Biology	1999	326
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth Brion W. Murray, Chuangxing Guo, Joseph Piraino, Proceedings of the National Academy of Sciences	2010	318
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance Phillip A. Schwartz, Petr Kuzmič, James Solowiej, Proceedings of the National Academy of Sciences	2013	271

Page 1